Finding 961214 (2023-006)

Significant Deficiency Repeat Finding
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2024-03-26
Audit: 297887
Organization: Legacy Medical Care Inc. (IL)

AI Summary

  • Core Issue: Legacy failed to document checks on sam.gov for vendor eligibility before contracting, leading to a significant deficiency in internal controls.
  • Impacted Requirements: Compliance with 2 CFR sections 200.212 and 200.318(h) regarding vendor suspension and debarment verification.
  • Recommended Follow-Up: Ensure timely documentation of sam.gov checks for all vendors before contracts are signed to avoid future compliance issues.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Grants for New and Expanded Services Under the Health Center Program Assistance Listing Number: 93.224/93.527 Federal Award Identification Number: L2C42352-01-00 Award Periods: July 1, 2021 – June 30, 2023 Type of Finding: Significant deficiency in internal control over compliance Criteria: 2 CFR sections 200.212 and 200.318(h); 2 CFR section 180.300; 48 CFR section 52.209-6 outlines that the non-federal entity must verify that the agency in which it is entering into a contract is not suspended or debarred or otherwise excluded from participating in the transaction. Condition: Legacy did not document that sam.gov was checked prior to entering into a contract with a vendor. Questioned Costs: None. Context: Two (2) of two (2) vendors tested. Documentation was provided to show that sam.gov was checked, however it occurred on the last day of the fiscal year. Cause: Legacy did not create and maintain documentation showing that suspension and debarment had be checked prior to engaging a vendor. Effect: Contracted vendors may be ineligible to receive federal dollars for services performed. Repeat Finding: Yes. Prior Year Finding: 2022-003. Recommendation: We recommend that Legacy check, and document, the use of Sam.gov to verify that a vendor was not suspended, debarred, or otherwise excluded from participating in the transaction prior to entering into a contract. Views of Responsible Officials: There is no disagreement with the audit finding.

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 384770 2023-002
    Significant Deficiency
  • 384771 2023-005
    Material Weakness Repeat
  • 384772 2023-006
    Significant Deficiency Repeat
  • 384773 2023-003
    Significant Deficiency
  • 384774 2023-004
    Significant Deficiency Repeat
  • 961212 2023-002
    Significant Deficiency
  • 961213 2023-005
    Material Weakness Repeat
  • 961215 2023-003
    Significant Deficiency
  • 961216 2023-004
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.268 Immunization Cooperative Agreements $210,112
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $82,636
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $64,146
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated and State Partnership Marketplaces $34,711